Voloridge Investment Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-37,154
Closed -$2.5M 1274
2023
Q4
$2.5M Sell
37,154
-27,966
-43% -$1.95M 0.01% 780
2023
Q3
$4.87M Sell
65,120
-3,656
-5% -$324K 0.02% 668
2023
Q2
$6.34M Sell
68,776
-4,069
-6% -$362K 0.03% 592
2023
Q1
$7.55M Buy
+72,845
New +$8.07M 0.04% 544
2022
Q3
Sell
-44,761
Closed -$8.08M 1535
2022
Q2
$8.08M Sell
44,761
-10,600
-19% -$1.9M 0.04% 519
2022
Q1
$9.46M Buy
55,361
+22,540
+69% +$4.25M 0.05% 424
2021
Q4
$6.87M Buy
32,821
+15,155
+86% +$3.13M 0.04% 594
2021
Q3
$3.4M Buy
17,666
+13,292
+304% +$3.27M 0.02% 840
2021
Q2
$1.24M Sell
4,374
-831
-16% -$225K 0.01% 1173
2021
Q1
$1.1M Sell
5,205
-4,628
-47% -$1.11M 0.01% 999
2020
Q4
$1.93M Sell
9,833
-10,547
-52% -$1.86M 0.02% 756
2020
Q3
$3.35M Buy
+20,380
New +$3.36M 0.03% 558
2019
Q4
Sell
-17,386
Closed -$1.8M 1248
2019
Q3
$1.8M Buy
+17,386
New +$1.87M 0.03% 480
2019
Q2
Sell
-15,532
Closed -$1.98M 943
2019
Q1
$1.98M Sell
15,532
-4,008
-21% -$508K 0.06% 293
2018
Q4
$2.44M Buy
+19,540
New +$3.34M 0.11% 182

Other funds holding MED

Voloridge Investment Management's MED Position: Q1 2024 in Review

Voloridge Investment Management sold out of Medifast (MED) in Q1 2024, closing a stake of 37,154 shares — an estimated $2.5M sold.

Voloridge Investment Management first reported a position in MED in Q4 2018 and held it in 15 quarters. The position peaked at $9.46M in Q1 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Voloridge Investment Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 37,154 Medifast shares in Q1 2024, an estimated $2.5M.
  • Voloridge Investment Management first reported a position in Medifast in Q4 2018 and held it in 15 quarters.
  • Voloridge Investment Management's Medifast position peaked at $9.46M in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Voloridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.